Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# CEL220: A Phase IV, Single Center Pilot Study Using Alemtuzumab (CAMPATH-1H) Induction Combined with Prednisone-Free and Calcineurin-Inhibitor-Free Immunosuppression in Kidney Transplantation
Leventhal, Joseph R
(PD/PI)
Gallon, Lorenzo
(Co-PD/PI)
Surgery, Transplant Surgery Division
Medicine, Nephrology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
1/25/05
→
11/1/11
Funding
Roche Laboratories Inc.
(CEL220)
View all
View less